# US 2012/0083762 A1 · Method of delivering material or stimulus to a biological subject

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0083762 A1
- Document ID: US20120083762A1
- Status: Published application
- Kind: A1
- Application number: 13/251,920
- Filed: 2011-10-03
- Published: 2012-04-05
- Earliest claimed: 2004-01-30
- Assignees: Vaxxas Pty Limited
- Inventors: Mark Anthony Fernance Kendall
- Web page: https://patentgrep.com/patent/US20120083762A1

## CPC

- A61B 17/205: {Vaccinating by means of needles or other puncturing devices}
- A61M 37/0015: {by using microneedles}
- A61M 2037/0046: {Solid microneedles}
- B33Y 80/00: Products made by additive manufacturing
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- B33Y: ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING

## Abstract

A device for delivery of material or stimulus to targets within a body to produce a desired response, the targets being at least one of cells of interest, cell organelles of interest and cell nuclei of interest. The device includes a number of projections for penetrating a body surface, with the number of projections being selected to produce a desired response, and the number being at least 500. A spacing between projections is also at least partially determined based on an arrangement of the targets within the body.

## Claims

### Claim at position 1

1-45. (canceled)

### Claim 46

A method of delivering material or stimulus to a biological subject, the method comprising applying a device to the biological subject, the device comprising:
a) a base; and
b) projections extending from the base, wherein each projection comprises a tip for penetrating a surface of the biological subject, and wherein:
i) the number of projections is at least 500;
ii) each projection has a length of between 200 μm and 1000 μm;
iii) each projection has a base width of between 5 μm and 50 μm; and
iv) projections are separated by a spacing of between 10 μm and 200 μm.

### Claim 47 (depends on 46)

A method according to claim 46, wherein the device is used to deliver material or stimulus to one or more cells within the biological subject.

### Claim 48 (depends on 47)

A method according to claim 47, wherein the device is used to deliver material or stimulus to one or more dermal cells.

### Claim 49 (depends on 46)

A method according to claim 46, wherein the tips of the projections penetrate the surface of the biological subject to thereby deliver material or stimulus to the biological subject.

### Claim 50 (depends on 49)

A method according to claim 49, wherein at least the tips of one or more of the projections penetrate the dermis of the biological subject to thereby deliver material or stimulus to dermal cells within the biological subject.

### Claim 51 (depends on 46)

A method according to claim 46, wherein the method comprises providing a coating on at least part of one or more of the projections, and wherein the device is used to deliver at least some of the coating to the biological subject.

### Claim 52 (depends on 51)

A method according to claim 51, wherein the coating is a bioactive material for delivery to the biological subject.

### Claim 53 (depends on 51)

A method according to claim 51, wherein the coating is a non-liquid coating including a material for delivery to the biological subject.

### Claim 54 (depends on 51)

A method according to claim 51, wherein the coating is selected from the group consisting of:
a) nanoparticles;
b) a nucleic acid or protein;
c) an antigen, allergen, or adjuvant;
d) parasites, bacteria, viruses, or virus-like particles;
e) quantum dots, SERS tags, raman tags or other nanobiosensors;
f) metals or metallic compounds;
g) molecules, elements or compounds; and
h) mixtures thereof.

### Claim 55 (depends on 51)

A method according to claim 51, wherein the coating comprises a vaccine for delivery to the biological subject to thereby produce an immunological response within the biological subject.

### Claim 56 (depends on 51)

A method according to claim 51, wherein the coating comprises one or more antigens for delivery to the biological subject to thereby produce a tolerogenic response within the biological subject.

### Claim 57 (depends on 46)

A method according to claim 46, wherein one or more of the projections perturb cells within the biological subject to thereby induce bystander responses.

### Claim 58 (depends on 46)

A method according to claim 46, wherein the device includes one or more uncoated projections which stimulate or perturb cells within the biological subject upon penetrating the surface of the biological subject.

### Claim 59 (depends on 46)

A method according to claim 46, wherein at least part of one or more of the projections at least partially dissolves upon penetrating the surface of the biological subject.

### Claim 60 (depends on 59)

A method according to claim 59, wherein a bioactive material is incorporated into the projections, and wherein the bioactive material is delivered to cells within the biological subject as the at least part of one of more of the projections dissolve.

### Claim 61 (depends on 46)

A method according to claim 46, wherein the method comprises applying the device to the biological subject by inserting at least the tips of the projections into the surface with an insertion force.

### Claim 62 (depends on 61)

A method according to claim 61, wherein the device is applied using an applicator having an actuator for providing the insertion force.

### Claim 63 (depends on 61)

A method according to claim 61, wherein the insertion force is determined at least in part based on mechanical properties of tissues of the biological subject to be penetrated.

### Claim 64 (depends on 61)

A method according to claim 61, wherein the insertion force is less than 1 N.

### Claim 65 (depends on 46)

A method according to claim 46, wherein the method comprises:
a) inserting the projections through the surface of the biological subject and into tissues of interest within the biological subject;
b) holding the device in place for a sufficient time to produce a desired response within the biological subject; and
c) retracting the device from the biological subject.

### Claim 66 (depends on 65)

A method according to claim 65, wherein the tissues of interest comprise the dermis of the biological subject.

### Claim 67 (depends on 65)

A method according to claim 65, wherein the projections are coated with a vaccine, and wherein the desired response is an immunological response.

### Claim 68

A method of delivering vaccine to a biological subject to produce an immunological response, the method comprising applying a device to the biological subject, the device comprising:
a) a base; and
b) projections extending from the base, wherein each projection comprises a tip for penetrating a surface of the biological subject, and wherein:
i) the number of projections is at least 500;
ii) each projection has a length of between 200 μm and 1000 μm;
iii) each projection has a base width of between 5 μm and 50 μm;
iv) projections are separated by a spacing of between 10 μm and 200 μm; and
v) one or more of the projections are at least partially coated with a vaccine.

### Claim 69 (depends on 68)

A method according to claim 68, wherein the tips of the projections penetrate the surface of the biological subject to thereby deliver the vaccine to the biological subject.

### Claim 70 (depends on 68)

A method according to claim 68, wherein at least part of one or more of the projections partially or fully dissolve upon penetrating the surface of the biological subject, thereby delivering the vaccine to biological subject.

### Claim 71

A method for delivering material to a biological subject, the method comprising applying a device to the biological subject, the device comprising:
a) a base; and
b) projections extending from the base, wherein each projection comprises a tip for penetrating a surface of the biological subject, and wherein at least part of at least some of the projections is coated, and wherein:
i) the number of projections is at least 500;
ii) each projection has a length of between 200 μm and 1000 μm;
iii) each projection has a base width of between 5 μm and 50 μm; and
iv) projections are separated by a spacing of between 10 μm and 200 μm.

### Claim 72 (depends on 71)

A method according to claim 71, wherein the coating is a non-liquid coating including a bioactive material.

### Claim 73 (depends on 71)

A method according to claim 71, wherein the device is used to deliver material to cells within the biological subject.

### Claim 74

A method for delivering stimulus to a biological subject, the method comprising applying a device to the biological subject, the device comprising:
a) a base; and
b) projections extending from the base, wherein each projection comprises a tip for penetrating a surface of the biological surface, and wherein:
i) the number of projections is at least 500;
ii) each projection has a length of between 200 μm and 1000 μm;
iii) each projection has a base width of between 5 μm and 50 μm; and
iv) projections are separated by a spacing of between 10 μm and 200 μm.

### Claim 75 (depends on 74)

A device according to claim 74, wherein at least some of the projections perturb cells within the biological subject to thereby induce bystander responses.

### Claim 76

A method of treating a biological subject, the method comprising applying a skin penetrating device to a biological subject, the device comprising:
a) a base; and
b) a number of projections extending from the base, wherein the projections are arranged in an array, and wherein each projection comprises a tip for penetrating a surface of the biological subject, and wherein:
i) the number of projections is at least 500;
ii) each projection has a length of between 200 μm and 1000 μm;
iii) each projection has a base width of between 5 μm and 50 μm; and
iv) projections are separated by a spacing of between 10 μm and 200 μm.

### Claim 77

A method of treating a biological subject, the method comprising using a device for delivery of material or stimulus biological subject, the device comprising:
a) a base; and
b) projections extending from the base, wherein each projection comprises a tip for penetrating a surface of the biological subject, and wherein:
i) the number of projections is at least 500;
ii) each projection has a length of between 200 μm and 1000 μm;
iii) each projection has a base width of between 5 μm and 50 μm; and
iv) projections are separated by a spacing of between 10 μm and 200 μm.

### Claim 78

A method of treating a subject, the method comprising using a device for delivery of material or stimulus to targets within the subject's body to produce a desired response, the targets being at least one of cells of interest, cell organelles of interest and cell nuclei of interest, the device comprising a number of projections for penetrating a body surface, and wherein:
a) the number of projections is selected to produce a desired response, the number being at least 500; and,
b) a spacing between projections is at least partially determined based on an arrangement of the targets within the body.
